claim
In the study published by Clara Bodelon, tamoxifen did not show any notable decline in physical health, whereas aromatase inhibitors accounted for all the physical health decline observed within the endocrine therapy group.
Authors
Sources
- Crucial Answers on Long-Term Physical Health Effects From Breast ... www.cancernetwork.com via serper
Referenced by nodes (1)
- endocrine therapy concept